Storz P, 2005, Front Biosci, 10, 1881, 10.2741/1667
Szatrowski TP, 1991, Cancer Res, 51, 794
Babior BM, 1999, Blood, 93, 1464, 10.1182/blood.V93.5.1464
Han D, 2001, Biochem J, 353, 411, 10.1042/bj3530411
Crompton M, 1999, Biochem J, 341, 233, 10.1042/bj3410233
Bienert GP, 2007, J Biol Chem, 282, 1183, 10.1074/jbc.M603761200
Lee WK, 2006, Am J Physiol Cell Physiol, 291, C195, 10.1152/ajpcell.00641.2005
Dansen TB, 2001, IUBMB Life, 51, 223, 10.1080/152165401753311762
del Rio LA, 1992, Free Radic Biol Med, 13, 557, 10.1016/0891-5849(92)90150-F
Singh I, 1996, Ann N Y Acad Sci, 804, 612, 10.1111/j.1749-6632.1996.tb18648.x
Bonekamp NA, 2009, Biofactors, 35, 346, 10.1002/biof.48
Bae YS, 2000, J Biol chem, 275, 10527, 10.1074/jbc.275.14.10527
Burdon RH, 1995, Free Radic biol med, 18, 775, 10.1016/0891-5849(94)00198-S
Goustin AS, 1986, Cancer Res, 46, 1015
Sundaresan M, 1995, Science, 270, 296, 10.1126/science.270.5234.296
Tiku ML, 1990, Enhancement by cytokines. J Immunol, 145, 690
Lo YY, 1995, J Biol chem, 270, 11727, 10.1074/jbc.270.20.11727
Roy D, 2006, Front Biosci, 11, 889, 10.2741/1845
Ohba M, 1994, J Cell Biol, 126, 1079, 10.1083/jcb.126.4.1079
Griendling KK, 1994, Circ Res, 74, 1141, 10.1161/01.RES.74.6.1141
Aunoble B, 2000, Int J Oncol, 16, 567
Minamoto T, 2000, Cancer Detect Prev, 24, 1
Minamoto T, 2002, Expert Rev Mol Diagn, 2, 565, 10.1586/14737159.2.6.565
10.1016/j.cellsig.2006.11.009
Ferraro D, 2006, Oncogene, 25, 3689, 10.1038/sj.onc.1209409
Shin EA, 1999, FEBS Lett, 452, 355, 10.1016/S0014-5793(99)00657-2
Balkwill F, 2009, Nat Rev Cancer, 9, 361, 10.1038/nrc2628
10.1111/j.1749-6632.2009.03704.x
Xiao H, 2008, Int J Cancer, 123, 983, 10.1002/ijc.23718
Babior BM, 1995, Curr Opin Hematol, 2, 55, 10.1097/00062752-199502010-00008
10.1111/j.1749-6632.1997.tb46249.x
Cui S, 1994, Cancer Res, 54, 2462
Copin JC, 2000, Free Radic Biol Med, 28, 1571, 10.1016/S0891-5849(00)00280-X
Bendayan M, 1982, Lab Invest, 47, 364
Hashimoto F, 1990, J Biochem, 108, 426, 10.1093/oxfordjournals.jbchem.a123217
Litwin JA, 1987, Am J Pathol, 128, 141
Hofmann B, 2002, Biol Chem, 383, 347
Wood ZA, 2003, Trends Biochem Sci, 28, 32, 10.1016/S0968-0004(02)00003-8
Neumann CA, 2003, Nature, 424, 561, 10.1038/nature01819
Holmgren A, 1995, Structure, 3, 239, 10.1016/S0969-2126(01)00153-8
Arner ES, 2000, Eur J Biochem, 267, 6102, 10.1046/j.1432-1327.2000.01701.x
Mustacich D, 2000, Biochemical J, 346, 1, 10.1042/bj3460001
Brigelius-Flohe R, 1999, Free Radic biol Med, 27, 951, 10.1016/S0891-5849(99)00173-2
Ursini F, 1995, Methods in Enzymol, 252, 38, 10.1016/0076-6879(95)52007-4
Carlberg I, 1975, J Biol Chem, 250, 5475, 10.1016/S0021-9258(19)41206-4
Beutler E, 1969, J Clin Invest, 48, 1957, 10.1172/JCI106162
Townsend DM, 2003, Oncogene, 22, 7369, 10.1038/sj.onc.1206940
Sharma R, 2004, Antioxid & Redox signal, 6, 289, 10.1089/152308604322899350
Hayes JD, 2005, Annu Rev Pharmacol Toxicol, 45, 51, 10.1146/annurev.pharmtox.45.120403.095857
Colavitti R, 2002, J Biol Chem, 277, 3101, 10.1074/jbc.M107711200
10.1016/S0014-5793(00)01669-0
Irani K, 2000, Circulation Res, 87, 179, 10.1161/01.RES.87.3.179
Rhee SG, 2000, Sci STKE, 53
Roberts PJ, 2007, Oncogene, 26, 3291, 10.1038/sj.onc.1210422
Irani K, 1997, Science, 275, 1649, 10.1126/science.275.5306.1649
Reddy KB, 2007, Int J Oncol, 30, 971
Lander HM, 1997, Structural basis for the nitric oxide-p21(ras) interaction, 272, 4323
Chan DW, 2008, Carcinogenesis, 29, 1742, 10.1093/carcin/bgn167
McCubrey JA, 2007, Biochim Biophys Acta, 1773, 1263, 10.1016/j.bbamcr.2006.10.001
Steelman LS, 2008, Leukemia, 22, 686, 10.1038/leu.2008.26
10.1158/0008-5472.CAN-07-5259
10.1007/s11064-005-2449-y
Rygiel TP, 2008, J Cell Sci, 121, 1183, 10.1242/jcs.017194
Zhou J, 2008, Mol Cancer Res, 6, 194, 10.1158/1541-7786.MCR-07-0197
Cullen JJ, 2003, Cancer Res, 63, 1297
Lewis A, 2005, Clin Exp Metastasis, 22, 523, 10.1007/s10585-005-4919-7
Mazzio EA, 2004, J Appl Toxicol, 24, 99, 10.1002/jat.954
Zhang Y, 2002, Cancer Res, 62, 1205
Osada S, 2008, Cancer Chemother Pharmacol, 62, 315, 10.1007/s00280-007-0610-9
Shi Y, 2008, BMC Cancer, 8, 294, 10.1186/1471-2407-8-294
Brunet A, 1999, Cell, 96, 857, 10.1016/S0092-8674(00)80595-4
Pastorino JG, 1999, J Biol Chem, 274, 19411, 10.1074/jbc.274.27.19411
Xin M, 2005, J Biol Chem, 280, 10781, 10.1074/jbc.M500084200
10.1371/journal.pone.0001058
Qi XJ, 2006, J Biol Chem, 281, 813, 10.1074/jbc.M505546200
10.1182/blood-2004-02-0452
Burdick AD, 2003, Cancer Res, 63, 7825
Park SA, 2009, Cancer Res, 69, 2416, 10.1158/0008-5472.CAN-08-2177
Liu LZ, 2006, Free Radic Biol Med, 41, 1521, 10.1016/j.freeradbiomed.2006.08.003
Mochizuki T, 2006, Oncogene, 25, 3699, 10.1038/sj.onc.1209406
Storz P, 2002, Front Biosci, 7, d886, 10.2741/storz
Ogg S, 1998, Mol Cell, 2, 887, 10.1016/S1097-2765(00)80303-2
Sun H, 1999, Proc Natl Acad Sci USA, 96, 6199, 10.1073/pnas.96.11.6199
Higaki Y, 2008, Am J Physiol Endocrinol Metab, 294, E889, 10.1152/ajpendo.00150.2007
Prasad N, 2000, Biochemistry, 39, 6929, 10.1021/bi000387i
Lee SR, 2002, J Biol Chem, 277, 20336, 10.1074/jbc.M111899200
Huo YY, 2008, Free Radic Biol Med, 44, 1578, 10.1016/j.freeradbiomed.2008.01.013
Basseres DS, 2006, Oncogene, 25, 6817, 10.1038/sj.onc.1209942
Biswas DK, 2006, J Cell Physiol, 209, 645, 10.1002/jcp.20785
Biswas DK, 2004, Proc Natl Acad Sci USA, 101, 10137, 10.1073/pnas.0403621101
Rayet B, 1999, Oncogene, 18, 6938, 10.1038/sj.onc.1203221
Ahmed KM, 2006, Anticancer Res, 26, 4235
Bourguignon LY, 2009, J Biol Chem, 284, 2657, 10.1074/jbc.M806708200
Duffey DC, 2000, Br J Cancer, 83, 1367, 10.1054/bjoc.2000.1423
Li N, 1999, Faseb J, 13, 1137, 10.1096/fasebj.13.10.1137
10.3109/10715769209079515
Beg AA, 1993, Mol Cell Biol, 13, 3301, 10.1128/MCB.13.6.3301
Beg AA, 1992, Genes Dev, 6, 1899, 10.1101/gad.6.10.1899
Bonizzi G, 2004, Embo J, 23, 4202, 10.1038/sj.emboj.7600391
Delhase M, 1999, Science, 284, 309, 10.1126/science.284.5412.309
Hacker H, 2006, Sci STKE, 357, re13
Bergmann M, 1998, Requirement for an additional activation pathway, 273, 6607
Claudio E, 1996, Exp Cell Res, 224, 63, 10.1006/excr.1996.0111
Ling L, 1998, Proc Natl Acad Sci USA, 95, 3792, 10.1073/pnas.95.7.3792
Ghoda L, 1997, J Biol Chem, 272, 21281, 10.1074/jbc.272.34.21281
Singh S, 1996, J Biol Chem, 271, 31049, 10.1074/jbc.271.49.31049
Karin M, 2008, Cell Res, 18, 334, 10.1038/cr.2008.30
Janssen-Heininger YM, 2000, Free Radic Biol Med, 28, 1317, 10.1016/S0891-5849(00)00218-5
Li Q, 2006, J Biol Chem, 281, 1495, 10.1074/jbc.M511153200
Manna SK, 1998, J Biol Chem, 273, 13245, 10.1074/jbc.273.21.13245
Ruiz-Ramos R, 2009, Mutat Res, 674, 109, 10.1016/j.mrgentox.2008.09.021
Wang Y, 2007, Free Radic Res, 41, 963, 10.1080/10715760701445045
Storz P, 2004, Mol Cell Biol, 24, 2614, 10.1128/MCB.24.7.2614-2626.2004
Storz P, 2003, The EMBO J, 22, 109, 10.1093/emboj/cdg009
Cowell CF, 2009, J Cell Sci, 122, 919, 10.1242/jcs.041061
Doppler H, 2007, J Biol chem, 282, 31873, 10.1074/jbc.M703584200
Imbert V, 1996, Cell, 86, 787, 10.1016/S0092-8674(00)80153-1
Mukhopadhyay A, 2000, J Biol chem, 275, 8549, 10.1074/jbc.275.12.8549
Gupta A, 1999, Carcinogenesis, 20, 2063, 10.1093/carcin/20.11.2063
10.3109/10715769009109669
Felty Q, 2005, J Carcinog, 4, 1, 10.1186/1477-3163-4-1
Felty Q, 2005, Oncogene, 24, 4883, 10.1038/sj.onc.1208667
Felty Q, 2005, Biochemistry, 44, 6900, 10.1021/bi047629p
Sarsour EH, 2008, Aging cell, 7, 405, 10.1111/j.1474-9726.2008.00384.x
Wang M, 2005, Oncogene, 24, 8154, 10.1038/sj.onc.1208986
Parkash J, 2006, Biochemistry, 45, 2872, 10.1021/bi051855x
Menon SG, 2005, Antioxid Redox Signal, 7, 711, 10.1089/ars.2005.7.711
Behrend L, 2003, Biochem Soc Trans, 31, 1441, 10.1042/bst0311441
Browne SE, 2004, Free Radic Biol Med, 36, 938, 10.1016/j.freeradbiomed.2004.01.003
Reichenbach J, 2002, Antioxidants & redox signaling, 4, 465, 10.1089/15230860260196254
Cadenas E, 2004, Mol Aspects Med, 25, 17, 10.1016/j.mam.2004.02.005
Simon HU, 2000, Apoptosis, 5, 415, 10.1023/A:1009616228304
Chung YM, 2003, Free Radic Biol Med, 34, 434, 10.1016/S0891-5849(02)01301-1
Storz P, 2007, Trends Cell Biol, 17, 13, 10.1016/j.tcb.2006.11.003
Gottlieb E, 2000, Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol, 20, 5680
Lee CH, 2008, Cancer, 113, 815, 10.1002/cncr.23619
Qanungo S, 2005, Carcinogenesis, 26, 958, 10.1093/carcin/bgi040
Shim H, 2007, Mol Cells, 24, 95, 10.1016/S1016-8478(23)10760-6
Zhang R, 2008, Apoptosis, 13, 1465, 10.1007/s10495-008-0278-6
Saitoh M, 1998, EMBO J, 17, 2596, 10.1093/emboj/17.9.2596
Takeda K, 2003, Cell Struct Funct, 28, 23, 10.1247/csf.28.23
You H, 2006, Proc Natl Acad Sci USA, 103, 9051, 10.1073/pnas.0600889103
Schulze-Osthoff K, 1993, EMBO J, 12, 3095, 10.1002/j.1460-2075.1993.tb05978.x
Xu YC, 2002, J Biol Chem, 277, 28051, 10.1074/jbc.M202665200
Chiu TT, 2007, Am J Physiol Cell Physiol, 292, C767, 10.1152/ajpcell.00308.2006
Mihailovic T, 2004, Cancer Res, 64, 8939, 10.1158/0008-5472.CAN-04-0981
Song J, 2009, Biochem Biophys Res Commun, 378, 610, 10.1016/j.bbrc.2008.11.106
Storz P, 2005, Biochem J, 387, 47, 10.1042/BJ20041443
10.1128/MCB.25.19.8520-8530.2005
Zhang W, 2005, J Biol Chem, 280, 19036, 10.1074/jbc.M414674200
Kundu N, 1995, Clin Exp Metastasis, 13, 16, 10.1007/BF00144014
Pelicano H, 2009, Cancer Res, 69, 2375, 10.1158/0008-5472.CAN-08-3359
Hitchler M. J, 2008, Free Radic Biol Med, 45, 1573, 10.1016/j.freeradbiomed.2008.09.005
Broom OJ, 2006, J Cell Physiol, 209, 950, 10.1002/jcp.20796
Svineng G, 2008, Connect Tissue Res, 49, 197, 10.1080/03008200802143166
Ben Mahdi MH, 2000, IUBMB Life, 50, 291, 10.1080/15216540051081038
Chiarugi P, 2008, IUBMB Life, 60, 301, 10.1002/iub.45
Werner E, 2002, J Cell Biol, 158, 357, 10.1083/jcb.200111028
Giannoni E, 2009, Oncogene, 28, 2074, 10.1038/onc.2009.77
Radisky DC, 2005, Nature, 436, 123, 10.1038/nature03688
Wu WS, 2006, Cancer Metastasis Rev, 25, 695, 10.1007/s10555-006-9037-8
Tobar N, 2008, Cancer Lett, 267, 125, 10.1016/j.canlet.2008.03.011
Moldovan L, 1999, Antioxid Redox signal, 1, 29, 10.1089/ars.1999.1.1-29
Eiseler T, 2009, Nat cell Biol, 11, 545, 10.1038/ncb1861
Kim JS, 2009, Mol Biol Cell, 20, 2650, 10.1091/mbc.E09-02-0131
Gianni D, 2008, Mol Biol Cell, 19, 2984, 10.1091/mbc.E08-02-0138
Diaz B, 2009, Sci Signal, 2, ra53, 10.1126/scisignal.2000368
Brown NS, 2001, Breast Cancer Res, 3, 323, 10.1186/bcr315
Nelson AR, 2000, J Clin Oncol, 18, 1135, 10.1200/JCO.2000.18.5.1135
Nelson KK, 2004, Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med, 37, 768
Brenneisen P, 2002, Ann NY Acad Sci, 973, 31, 10.1111/j.1749-6632.2002.tb04602.x
Kheradmand F, 1998, Science, 280, 898, 10.1126/science.280.5365.898
Wenk J, 1999, J Biol Chem, 274, 25869, 10.1074/jbc.274.36.25869
Westermarck J, 1999, Faseb J, 13, 781, 10.1096/fasebj.13.8.781
Rajagopalan S, 1996, Implications for atherosclerotic plaque stability. J Clin Invest, 98, 2572
van Wetering S, 2002, J Cell Sci, 115, 1837, 10.1242/jcs.115.9.1837
Cheng GC, 2004, Exp Cell Res, 300, 297, 10.1016/j.yexcr.2004.07.014
Roebuck KA, 1999, Int J Mol Med, 4, 223
Dewhirst MW, 2008, Nat Rev Cancer, 8, 425, 10.1038/nrc2397
Hockel M, 2001, J Natl Cancer Inst, 93, 266, 10.1093/jnci/93.4.266
Pani G, 2009, Antioxidants Redox Signal, 11, 2791, 10.1089/ars.2009.2739
Dang CV, 1999, Trends Biochem Sci, 24, 68, 10.1016/S0968-0004(98)01344-9
Ganapathy V, 2009, Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther, 121, 29
Hsu PP, 2008, Cell, 134, 703, 10.1016/j.cell.2008.08.021
Harris AL, 2002, Nat Rev Cancer, 2, 38, 10.1038/nrc704
Kaelin WG, 2008, Mol Cell, 30, 393, 10.1016/j.molcel.2008.04.009
Pouyssegur J, 2006, Nature, 441, 437, 10.1038/nature04871
Erler JT, 2006, Nature, 440, 1222, 10.1038/nature04695
Rofstad EK, 2006, Cancer Res, 66, 6699, 10.1158/0008-5472.CAN-06-0983
Claffey KP, 1996, Cancer Res, 56, 172
Senger DR, 1994, Invasion Metastasis, 14, 385
Rabbani ZN, 2009, Free Radic Biol Med
Brown LF, 1997, Exs, 79, 233
Murakami M, 2008, Curr Opin Hematol, 15, 215, 10.1097/MOH.0b013e3282f97d98
Wouters BG, 2008, Nat Rev Cancer, 8, 851, 10.1038/nrc2501
Spitz DR, 2000, A fundamental defect in metabolism?, 899, 349
Bertout JA, 2008, Nat Rev Cancer, 8, 967, 10.1038/nrc2540
Xia C, 2007, Cancer Res, 67, 10823, 10.1158/0008-5472.CAN-07-0783
Govindarajan B, 2007, J Clin Invest, 117, 719, 10.1172/JCI30102
Ma J, 2009, Mol Cell Biochem
Wartenberg M, 2003, Lab Invest, 83, 87, 10.1097/01.LAB.0000049348.51663.2F
Milligan SA, 1996, Am J Physiol, 271, L114
Bao S, 2006, Nature, 444, 756, 10.1038/nature05236
Visvader JE, 2008, Nat Rev Cancer, 8, 755, 10.1038/nrc2499
Trachootham D, 2009, Nat Rev Drug Discov, 8, 579, 10.1038/nrd2803
Diehn M, 2009, Nature, 458, 780, 10.1038/nature07733
Tothova Z, 2007, Cell, 128, 325, 10.1016/j.cell.2007.01.003
Shackleton M, 2006, Nature, 439, 84, 10.1038/nature04372
Ward JF, 1985, Radiat Res Suppl, 8, S103, 10.2307/3583517
Imlay JA, 1988, Science, 240, 640, 10.1126/science.2834821
Maynard S, 2009, Carcinogenesis, 30, 2, 10.1093/carcin/bgn250
Mitra S, 2001, Environ Mol Mutagen, 38, 180, 10.1002/em.1070
Levine RL, 2002, Free Radic Biol Med, 32, 790, 10.1016/S0891-5849(02)00765-7
Squier TC, 2000, Front Biosci, 5, D504, 10.2741/Squier
Wells-Knecht MC, 1997, J Clin Invest, 100, 839, 10.1172/JCI119599
10.1016/S1097-2765(02)00445-8
Burhans WC, 2007, Nucleic Acids Res, 35, 7545, 10.1093/nar/gkm1059
Franco R, 2008, Cancer Lett, 266, 6, 10.1016/j.canlet.2008.02.026
Gardner HW, 1989, Free Radic Biol Med, 7, 65, 10.1016/0891-5849(89)90102-0
North JA, 1994, Am J Physiol, 267, C177, 10.1152/ajpcell.1994.267.1.C177
10.1016/j.chemphyslip.2008.09.004
Lauschke H, 2002, Results of a preliminary study. Eur Surg Res, 34, 346, 10.1159/000064002
Alexandre J, 2006, Int J Cancer, 119, 41, 10.1002/ijc.21685
Llobet D, 2008, Anticancer Drugs, 19, 115, 10.1097/CAD.0b013e3282f24031
Gahr S, 2007, Int J Oncol, 31, 567
Lee KH, 2009, Pancreatology, 9, 293, 10.1159/000186051
Shankar S, 2008, Front Biosci, 13, 440, 10.2741/2691
Shankar S, 2007, Front Biosci, 12, 5039, 10.2741/2446
Srivastava SK, 2004, Carcinogenesis, 25, 1701, 10.1093/carcin/bgh179
Donadelli M, 2007, Biochim Biophys Acta, 1773, 1095, 10.1016/j.bbamcr.2007.05.002
Sahu RP, 2009, Carcinogenesis
Marchetti M, 2009, PLoS One, 4, e5804, 10.1371/journal.pone.0005804
McLean L, 2008, Int J Cancer, 122, 1665, 10.1002/ijc.23244
Chen CY, 2007, Eur J Pharmacol, 574, 94, 10.1016/j.ejphar.2007.07.028
Kuo PL, 2007, Cancer Res, 67, 7406, 10.1158/0008-5472.CAN-07-1089
McLachlan A, 2005, Apoptosis, 10, 619, 10.1007/s10495-005-1896-x
10.1016/j.canlet.2005.01.035
Sandhya T, 2006, Cancer Lett, 238, 304, 10.1016/j.canlet.2005.07.013
Dayal D, 2009, Radiat Res, 172, 737, 10.1667/RR1617.1
Carew JS, 2003, Leukemia, 17, 1437, 10.1038/sj.leu.2403043
Aykin-Burns N, 2009, Biochem J, 418, 29, 10.1042/BJ20081258
Ahmad IM, 2008, Free Radic Biol Med, 44, 826, 10.1016/j.freeradbiomed.2007.11.007
Coleman MC, 2008, Free Radic Biol Med, 44, 322, 10.1016/j.freeradbiomed.2007.08.032
Algul H, 2007, Nat Clin Pract Gastroenterol Hepatol, 4, 454, 10.1038/ncpgasthep0881
Greer JB, 2009, Curr Opin Pharmacol
Lowenfels AB, 1993, N Engl J Med, 328, 1433, 10.1056/NEJM199305203282001
Antosiewicz J, 2006, Cancer Res, 66, 5379, 10.1158/0008-5472.CAN-06-0356
10.1016/j.biopha.2008.08.019
Storz P, 2009, Mol Cell Biol, 29, 4906, 10.1128/MCB.00077-09
